Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 4Breast Neoplasms 3Lung Neoplasms 2Depression 2Anxiety Disorders 2Unspecified Adult Solid Tumor, Protocol Specific 1Stress Disorders, Post-Traumatic 1Sedentary Behavior 1Rectal Neoplasms 1Prostatic Neoplasms 1Prostate Adenocarcinoma 1Prostate 1Pain 1Overweight 1Obesity 1Melanoma 1Lymphedema 1Leukemia 1Hematologic Neoplasms 1Fatigue 1Digestive System Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Anatomic Stage I Breast Cancer AJCC v8 1Adenocarcinoma, Bronchiolo-Alveolar 1Adenocarcinoma of Lung 1

Interventions

luprolide acetate gel depot 1enzalutamide 1entinostat 1apalutamide 1Triptorelin Pamoate 1Methods 1Leuprolide 1Goserelin 1Educational Status 1Early Intervention, Educational 1Counseling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Prostate Adenocarcinoma × Early Intervention, Educational × Clear all
NCT02168062 2020-07-23

Supportive Therapy in Androgen Deprivation Clinic in Improving Health Outcomes and Managing Side Effects in Patients With Prostate Cancer

University of California, San Francisco

Phase 2 Terminated
57 enrolled 27 charts
Genitourinary

Prostate Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡